High levels of triglycerides endanger cardiovascular health

Mgr. Iuliia Pavlovska is a doctoral student at Masaryk University in Brno and also a valid member of the research team of Kardiovize Brno 2030 of the International Clinical Research Center of St. Anne’s University Hospital Brno (FNUSA-ICRC). Her research focuses on the individual components of the metabolic syndrome and their effect on cardiovascular health.

She devoted her last article to the importance of controlling the level of triglycerides in the blood, which should not be higher than 1.7 mmol / l in the body. “The impulse came from the topic of my doctoral thesis, which deals with the connection between the metabolic syndrome and the problem of arterial stiffness,” described Mgr. Pavlovska and added: “When searching for professional articles, I noticed that they are describing infulence of triglycerides and abdominal obesity at least, so I focused on them.”

Samples of participants in this unique project were analyzed using state-of-the-art equipment available to the laboratories of the Kardiovize Brno 2030 research team. “There were data from the years 2013 – 2016, without this database I would be looking for a similar number of patients for years,” emphasized Mgr. Pavlovska. The analysis examined the relationship between high triglycerides and arterial stiffness using the CAVI (Cardio‑ Ankle Vascular Index; used to determine arterial stiffness, an indicator independent of blood pressure).

In close collaboration with researchers from the Mayo Clinic, high triglyceride levels have been shown to be associated with the early stages of cardiovascular disease. This information, together with targeted treatment for hypertriglyceridemia, could further contribute to reducing the number of cardiovascular diseases..

Source: https://lipidworld.biomedcentral.com/articles/10.1186/s12944-020-01345-0